Anticoagulation Market research
Pulmonary embolism (PE) is a major driver in the Anticoagulation Market. PE requires immediate anticoagulant therapy to prevent life-threatening complications. Increasing prevalence of PE due to aging populations
, sedentary lifestyles, and postoperative complications is boosting demand for anticoagulants. Improved diagnostic techniques allow early detection and timely intervention, further expanding the market. Pharmaceutical companies are focusing on PE-specific therapies to enhance treatment outcomes and reduce hospitalization, which strengthens market growth prospects.